Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.65 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.65 |
| ▸ | MAPT | P10636 | 1/20 | 0.64 |
| ▸ | RAB9A | P51151 | 5/20 | 0.45 |
| ▸ | NPC1 | O15118 | 4/20 | 0.45 |
| ▸ | NPSR1 | Q6W5P4 | 3/20 | 0.45 |
| ▸ | PKM | P14618 | 2/20 | 0.45 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 2/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.43 |
| ▸ | MIF | P14174 | 1/20 | 0.43 |
| ▸ | GAA | P10253 | 1/20 | 0.43 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2682040 | 0.72 | RAB9A (0.71) | ALDH1A1SMN1; SMN2MAPTRAB9ANPC1 | |
| SCHEMBL10674537 | 0.70 | ALDH1A1 (0.39) | ALDH1A1SMN1; SMN2LMNAKMT2A | |
| SCHEMBL27488421 | 0.68 | RAB9A (0.63) | ALDH1A1SMN1; SMN2MAPTRAB9ANPC1 | |
| SCHEMBL5139794 | 0.67 | RAB9A (0.65) | ALDH1A1SMN1; SMN2MAPTRAB9ANPC1 | |
| SCHEMBL6958678 | 0.67 | ALDH1A1 (0.62) | ALDH1A1SMN1; SMN2MAPTRAB9ANPC1 | |
| SCHEMBL6958684 | 0.67 | ALDH1A1 (0.62) | ALDH1A1SMN1; SMN2MAPTRAB9ANPC1 | |
| SCHEMBL6957562 | 0.67 | ALDH1A1 (0.58) | ALDH1A1SMN1; SMN2MAPTRAB9ANPC1 | |
| SCHEMBL6957565 | 0.67 | ALDH1A1 (0.58) | ALDH1A1SMN1; SMN2MAPTRAB9ANPC1 | |
| Hydrochloric Acid SCHEMBL27440821 | 0.66 | RAB9A (0.64) | ALDH1A1SMN1; SMN2MAPTRAB9ANPC1 | |
| SCHEMBL7345968 | 0.66 | HTT (0.60) | ALDH1A1SMN1; SMN2RAB9ANPC1NPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0270091-B1 | IMIDAZOLE DERIVATIVES, PROCESSES FOR THE PREPARATION OF THE SAME, PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME, THE USE OF THE SAME FOR THE MANUFACTURE OF MEDICAMENTS OF THERAPEUTIC VALUE, AND INTERMEDIATES FORMED DURING SAID PROCESSES | TANABE SEIYAKU CO., LTD. (JP) | 1992-11-11 | — | — | EP | disclosed |
| US-5053417-A | Antiulcer agents | TANABE SEIYAKU CO., LTD. (JP) | 1991-10-01 | — | — | US | disclosed |
| US-5002945-A | Antiulcer agents | TANABE SEIYAKU CO. LTD. (JP) | 1991-03-26 | — | — | US | disclosed |
| US-4996217-A | Antiulcer agents | TANABE SEIYAKU COMPANY, LTD. (JP) | 1991-02-26 | — | — | US | disclosed |
| EP-0270091-A1 | Imidazole derivatives, processes for the preparation of the same, pharmaceutical compositions comprising the same, the use of the same for the manufacture of medicaments of therapeutic value, and intermediates formed during said processes | TANABE SEIYAKU CO., LTD. (JP) | 1988-06-08 | — | — | EP | disclosed |